<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Chin Med J (Engl)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Chin. Med. J</journal-id>
      <journal-id journal-id-type="publisher-id">CMJ</journal-id>
      <journal-title-group>
        <journal-title>Chinese Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0366-6999</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25698209</article-id>
      <article-id pub-id-type="pmc">4834788</article-id>
      <article-id pub-id-type="publisher-id">CMJ-128-702</article-id>
      <article-id pub-id-type="doi">10.4103/0366-6999.151695</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Isoniazid and Pulmonary Fibrosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Chae Uk</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Dong Il</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Choong Sik</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jung</surname>
            <given-names>Sung Soo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Internal Medicine, Division of Pulmonology, College of Medicine, Chungnam National University, Deajeon 301-721, Korea</aff>
      <aff id="aff2"><label>2</label>Department of Pathology, College of Medicine, Chungnam National University, Deajeon 301-721, Korea</aff>
      <author-notes>
        <corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Sung Soo Jung, Department of Internal Medicine, Division of Pulmonology, Chungnam National University Hospital, Munhwa-Ro 33, Jung-Gu, Daejeon 301-747, Korea E-Mail: <email xlink:href="jss24lkm@hanmail.net">jss24lkm@hanmail.net</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>05</day>
        <month>3</month>
        <year>2015</year>
      </pub-date>
      <volume>128</volume>
      <issue>5</issue>
      <fpage>702</fpage>
      <lpage>703</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2015 Chinese Medical Journal</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>To the Editor: The anti-tuberculosis (TB) therapy can cause various drug adverse effects including hepatotoxicity, nephrotoxicity and skin rash.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] There are some case reports about interstitial lung disease (ILD) such as pneumonitis caused by isoniazid (INH), rifampin (RFP), ethambutol (EMB).[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] The causative drug was discontinued permanently or re-administrated after desensitization therapy. But the pulmonary fibrosis induced by short anti-TB medication was very rare. We herein report a case of pulmonary fibrosis due probably to INH, which was developed after 3 weeks of anti-TB treatment.</p>
    <p>A 42-year-old man was admitted to hospital due to continuous fever, night sweating, and weight loss for 1-month and exacerbated dyspnea on exercise (DOE) for 2 weeks. Chest posterioranterior showed right side pleural effusion [Figure <xref ref-type="fig" rid="F1">1a</xref> and <xref ref-type="fig" rid="F1">b</xref>]. Although pleural biopsy showed chronic inflammation, the effusion was exudates dominantly with lymphocyte cells and adenosine deaminase was 136.2 IU/L, highly suggesting TB pleurisy. Overall, he was diagnosed as TB pleurisy. INH, RFP, EMB, and pyrazinamide were administered, and the pleural effusion was drained with chest catheter. After taking anti-TB medication, symptoms diminished gradually but intermittent fever above 38&#xB0;C occurred. After 3 weeks of anti-TB medication, he complained of DOE and cough again, and the symptoms got worsened. The arterial gas blood analysis gave PaO<sub>2</sub> 41 mmHg, PaCO<sub>2</sub> 49 mmHg, and SaO<sub>2</sub> 86% on room air. Chest images showed no increase of pleural effusion but newly developed bilateral lung infiltrations including glass ground opacity, consolidation, and the reticular opacity [Figure <xref ref-type="fig" rid="F1">1c</xref> and <xref ref-type="fig" rid="F1">1d</xref>]. Because ILD induced by anti-TB medication was mostly suspected, all drugs were discontinued. To define the diagnosis of lung lesion, open lung biopsy was promptly performed. Biopsy at right lower lobe revealed chronic interstitial inflammation with fibrosis [<xref ref-type="fig" rid="F1">Figure 1e</xref>]. We considered provocation test confirming the causative drug, but we thought that drug challenge could aggravate the lung injury. Many references suggested that INH is most common cause of pneumonitis.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] At postoperation days 5, anti-TB medication except INH was started with prednisolone 60 mg and tapered. At 2 months after open lung biopsy, follow-up chest images showed combined pulmonary fibrosis and emphysema [<xref ref-type="fig" rid="F1">Figure 1f</xref>].</p>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>(a) Before initiation of anti-tuberculosis (TB) medication, chest posterioranterior (PA) showed right side pleural effusion; (b) Chest computed tomography (CT) scan before anti-TB medication; (c) After 3 weeks of anti-TB therapy, chest PA exhibited newly developed bilateral lung infiltrations; (d) After 3 weeks of anti-TB therapy, chest CT scan showed glass ground opacity, consolidation, and reticular opacity on both lower lobe; (e) Histological examination revealed chronic interstitial inflammation with fibrosis (H and E, original magnification &#xD7;100 and &#xD7;400); (f) Chest PA after 2 months of steroid therapy.</p>
      </caption>
      <graphic xlink:href="CMJ-128-702-g001"/>
    </fig>
    <p>The frequency of ILD caused by anti-TB medication is relatively rare, about 2%. The most frequently causative drug is INH and other drugs such as RFP and EMB also cause ILD.[<xref rid="ref4" ref-type="bibr">4</xref>] But there is no case report of the patient with INH-induced lung fibrosis. Pneumonitis induced by anti-TB medication causes some symptoms including fever, dyspnea, rash, and even chest pain. Among them, fever is the most common symptom.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] In this case, the patients complained of intermittent fever above 38&#xB0;C within first 10 days of TB treatment, the fever might be an early sign of pneumonitis. In this case, the lung fibrosis was developed very rapidly in 3 weeks of anti-TB medication, and the causative drug is probably INH. This case emphases that the clinician should consider the possibility of drug-induced pneumonitis or lung fibrosis even at initial phase of anti-TB treatment when the patient shows fever and complains of worsening of DOE.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="edited-by">
        <p><bold>Edited by:</bold> Jian Gao</p>
      </fn>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil.</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>R<sc>EFERENCES</sc></title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohta</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nagase</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Drug-induced interstitial lung disease</article-title>
          <source>Nihon Rinsho</source>
          <year>2012</year>
          <volume>70</volume>
          <issue>Suppl 6</issue>
          <fpage>517</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">23156562</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamanaka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sugiyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kitamura</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A case of isoniazid (INH)-induced pneumonitis</article-title>
          <source>Nihon Kyobu Shikkan Gakkai Zasshi</source>
          <year>1992</year>
          <volume>30</volume>
          <fpage>1563</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">1434231</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kunichika</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Miyahara</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kotani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takeyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanimoto</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Pneumonitis induced by rifampicin</article-title>
          <source>Thorax</source>
          <year>2002</year>
          <volume>57</volume>
          <fpage>1000</fpage>
          <lpage>1</lpage>
          <pub-id pub-id-type="pmid">12403887</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishizawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yasui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamamori</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tagami</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fujimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakao</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A case of successful desensitization therapy for isoniazid-induced pneumonitis</article-title>
          <source>Nihon Kokyuki Gakkai Zasshi</source>
          <year>2004</year>
          <volume>42</volume>
          <fpage>649</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="pmid">15357268</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Endo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ohse</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tamai</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A case of isoniazid-induced pneumonitis</article-title>
          <source>Nihon Kokyuki Gakkai Zasshi</source>
          <year>1998</year>
          <volume>36</volume>
          <fpage>100</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">9611986</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
